Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...

Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...

And despite the sales slump in the U.S. this past quarter, Pfizer’s Prevnar dynasty still leads in pediatric pneumococcal vaccination worldwide and among conjugated pneumococcal vaccines for adults in ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

On its third-quarter conference call held on Nov. 4, Pfizer PFE shed light on the two topics for which it has been in the ...